56 trends tracked about this subject — the full history, oldest to newest below.
Researchers at the National University of Singapore have identified a molecular 'master switch' and a corresponding drug target to combat aggressive breast cancer.
Recent medical studies highlight the role of laser ablation in extending survival for patients battling glioblastoma and other deadly brain tumors.
New research suggests that diets high in antioxidants may be linked to a significant reduction in the odds of developing cervical cancer.
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Wait times for cancer surgeries and treatments are increasing across the United States, prompting urgent calls for systemic healthcare reform.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Medical professionals are warning against dismissing unexplained bleeding and other subtle symptoms as signs of aging, particularly for those under age 40.
AstraZeneca ends a Phase 3 lung cancer drug trial for volrustomig after a formal review determines success is unlikely.
Medical professionals and new research studies are highlighting the metabolic, heart, and longevity benefits associated with habitual black coffee consumption.
Recent studies and reports indicate that artificial intelligence is delivering substantial cost savings and efficiency to oncology clinical trials.
Recent coverage examines rising lung cancer diagnoses among non-smokers, highlighting hidden environmental risks and screening gaps.
A novel pancreatic cancer drug is drawing widespread attention from medical professionals, patients, and national media outlets alike.
Pancreatic cancer specialists are focusing on the new drug daraxonrasib as multiple hospitals join a national initiative.
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Researchers have identified a specific prostate-specific antigen (PSA) threshold that serves as a key predictor for survival in metastatic prostate cancer patients.
Recent health research re-evaluates coffee consumption, showing it is not the heart risk doctors once thought.
Stanford-led scientists have discovered a flatworm immune cell that fights infection by detonating and erasing all traces of its existence within five minutes.
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
New research reveals how high glucose levels thicken the sugar shield of cancer cells, allowing them to remain invisible to the immune system.
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
A new study suggests Viagra may possess a health superpower by potentially slowing the spread of cancer cells.
Recent coverage examines whether popular weight-loss drugs like GLP-1 receptor agonists offer protective benefits against cancer.
Recent coverage examines the rising diagnosis rates of colon and gastrointestinal cancers among younger adults globally.
Health experts are warning that persistent mouth ulcers, hoarseness, and swallowing difficulties may be critical early indicators of head and neck cancer.
9 news sources are covering this Science story right now — PULSE is tracking how fast it spreads.
Oncologists warn that vaping may be creating a new wave of lung cancer, challenging the perception that e-cigarettes are a safer alternative to smoking.
A new AI-powered blood assay demonstrates the ability to detect liver cancer across diverse international populations to improve early diagnosis.
Scientific inquiries are examining the potential relationship between sugar consumption and the progression of cancer cells.
AstraZeneca’s earnings beat lifts its stock as oncology sales buoy growth and offset a rare drug miss.
A new study suggests that Viagra, originally designed for a different purpose, may have the potential to stop cancer from spreading.
A new brain implant called GammaTile is redefining postoperative radiation for brain metastases by shortening the gap between surgery and treatment.
Researchers have developed a fully human antibody drug capable of halting the growth and metastasis of aggressive prostate cancer in lab models.
Tempus AI is acquiring cancer-monitoring firm Personalis in a deal valued at approximately $1.5 billion, though market reaction has been negative.
Recent reporting focuses on longevity habits, notably an oncologist's advice on ice cream and wellness.
A Johns Hopkins-developed KRAS vaccine has demonstrated safety and durable immune responses in a trial focused on preventing pancreatic cancer in high-risk individuals.
A new modular in vivo antibody-ADC click chemistry approach aims to reverse drug resistance in tumors, including pancreatic cancer.
Medical research is exploring the intersection of GLP-1 receptor agonists and oncology, triggering debate over their potential role in cancer treatment.
Sanofi's Sarclisa becomes the first cancer drug to receive FDA approval for delivery via a wearable on-body injector for multiple myeloma patients.
Anthropic is entering the biotech sector with Claude Science, a new research workbench designed for drug discovery and studying overlooked diseases.
New research identifies 90 genes driving basal-like breast cancer, including 81 previously unknown targets linked to aneuploidy.
New global reports from the IARC and WHO indicate an upward trend in worldwide cancer cases, highlighting significant disparities in care and prevention.
The European Medicines Agency has fast-tracked the review of an experimental pancreatic cancer pill amid reports of significant clinical trial outcomes.
A prime‑editing tool for filamentous fungi is producing novel anti‑cancer compounds, drawing biotech attention.
Researchers have discovered a drug that blocks 90% of pancreatic cancer cell migration in lab tests by triggering cellular self-destruction.
9 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Mayo Clinic researchers have challenged decades of scientific understanding regarding the MHC I molecule and its role in the immune system's fight against cancer.
A new AACR report shows that while overall U.S. cancer death rates have dropped, significant disparities persist across geography and demographic groups.
Global reports highlight a rapid rise in liver cancer deaths, while experts indicate that 60% of cases may be preventable.
Johnson & Johnson CEO Joaquin Duato identifies the development of cures for certain types of cancer as a realistic objective for the coming decade.
New study data indicates that GLP-1 weight loss medications are associated with a significant reduction in the risk of developing four specific cancer types.
Medical researchers are exploring a new paradigm in oncology through early-detection blood tests and potential preventative drug treatments.
Prostate cancer awareness surges as experts debunk myths and highlight overlooked symptoms during Men’s Health Month
Pancreatic cancer treatment breakthrough sparks global medical and investment buzz
New diagnostic methods, including blood-based testing, are emerging as potential tools for the early detection and prevention of lung cancer.